The Relationship Between Age and Chronic Kidney Disease in Patients Undergoing Pancreatic Resection

  • Derrick Antoniak
  • Chandrakanth Are
  • Chad Vokoun
  • Kaeli Samson
  • Lynette Smith
  • Jason Shiffermiller
Original Article
  • 46 Downloads

Abstract

Background

Severe chronic kidney disease (CKD) predicts adverse outcomes in patients undergoing pancreatectomy, but the impact of milder CKD is unknown. Additionally, some authors have suggested that, due to physiologic changes of aging, CKD is over-diagnosed in patients above age 65.

Methods

Patients undergoing pancreatectomy for malignancy from 2005 to 2014 were identified from the National Surgical Quality Improvement Program. Primary outcomes were all-cause mortality and major complication, defined as myocardial infarction, cardiac arrest, stroke, venous thromboembolism, respiratory failure, deep surgical site infection, pneumonia, acute kidney injury, coma > 24 h, or re-operation occurring within 30 days of surgery.

Results

The mean age of 16,173 participants was 66 (range 18–90). Median preoperative creatinine was 0.80 mg/dL (0.10–11.0), and median preoperative eGFR was 86.36 mL/min/1.73m2 (2.98–182.2). Mortality and major complication occurred in 3 and 23% of patients, respectively. In adjusted analyses, CKD stages 2 (adjusted odds ratio (aOR) 1.24, 95% confidence interval (CI) 1.10–1.40), 3a (aOR 1.50, 95% CI 1.24–1.82), 3b (aOR 1.56, 95% CI 1.19–2.06), and 4 (aOR 2.17, 95% CI 1.25–3.76) were associated with increased major complication, and CKD stage 4 was associated with increased mortality (aOR 2.68, 95% CI 1.10–6.56). Age did not influence the relationship between CKD and either outcome.

Conclusion

CKD of any stage was associated with an increased risk of postoperative major complication, and severe CKD was associated with increased mortality among patients undergoing pancreatectomy for malignancy. These associations were not diminished in elderly patients. Our findings could inform preoperative counseling and decision-making.

Keywords

Pancreatic cancer Chronic renal insufficiency Glomerular filtration rate Perioperative period NSQIP 

Notes

Acknowledgements

The American College of Surgeons National Surgical Quality Improvement Program and the hospitals participating in the ACS NSQIP are the source of the data used herein; they have not verified and are not responsible for the statistical validity of the data analysis or the conclusions derived by the authors.

Compliance with Ethical Standards

Conflict of Interest

The authors declare that they have no conflicts of interest.

References

  1. 1.
    American Cancer Society. Cancer Facts & Figures, 2018. Available at: https://www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-statistics/annual-cancer-facts-and-figures/2018/cancer-facts-and-figures-2018.pdf. Accessed February 12, 2018, 2018.
  2. 2.
    Winter JM, Cameron JL, Campbell KA, Arnold MA, Chang DC, Coleman J, Hodgin MB, Sauter PK, Hruban RH, Riall TS, Schulick RD, Choti MA, Lillemoe KD, Yeo CJ. 1423 pancreaticoduodenectomies for pancreatic cancer: a single-institution experience. J Gastrointest Surg 2006; 10:1199–210; discussion 1210-1.Google Scholar
  3. 3.
    Cameron JL, Riall TS, Coleman J, Belcher KA. One thousand consecutive pancreaticoduodenectomies. Ann Surg 2006; 244:10–15.CrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.
    Cameron JL, He J. Two thousand consecutive pancreaticoduodenectomies. J Am Coll Surg 2015; 220:530–536.CrossRefPubMedGoogle Scholar
  5. 5.
    McPhee JT, Hill JS, Whalen GF, Zayaruzny M, Litwin DE, Sullivan ME, Anderson FA, Tseng JF. Perioperative mortality for pancreatectomy: a national perspective. Ann Surg 2007; 246:246–253.CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Are C, Afuh C, Ravipati L, Sasson A, Ullrich F, Smith L. Preoperative nomogram to predict risk of perioperative mortality following pancreatic resections for malignancy. J Gastrointest Surg 2009; 13:2152–2162.CrossRefPubMedGoogle Scholar
  7. 7.
    Reddy MA, Natarajan R. Recent developments in epigenetics of acute and chronic kidney diseases. Kidney Int 2015; 88:250–261.CrossRefPubMedPubMedCentralGoogle Scholar
  8. 8.
    Collins AJ, Foley RN, Chavers B, Gilbertson D, Herzog C, Johansen K, Kasiske B, Kutner N, Liu J, St Peter W, Guo H, Gustafson S, Heubner B, Lamb K, Li S, Li S, Peng Y, Qiu Y, Roberts T, Skeans M, Snyder J, Solid C, Thompson B, Wang C, Weinhandl E, Zaun D, Arko C, Chen SC, Daniels F, Ebben J, Frazier E, Hanzlik C, Johnson R, Sheets D, Wang X, Forrest B, Constantini E, Everson S, Eggers P, Agodoa L. ‘United States Renal Data System 2011 Annual data report: atlas of chronic kidney disease & end-stage renal disease in the United States. Am J Kidney Dis 2012; 59:A7, e1-420.Google Scholar
  9. 9.
    Sarnak MJ, Levey AS, Schoolwerth AC, Coresh J, Culleton B, Hamm LL, McCullough PA, Kasiske BL, Kelepouris E, Klag MJ, Parfrey P, Pfeffer M, Raij L, Spinosa DJ, Wilson PW, American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Circulation 2003; 108:2154–2169.Google Scholar
  10. 10.
    Shulman NB, Ford CE, Hall WD, Blaufox MD, Simon D, Langford HG, Schneider KA. Prognostic value of serum creatinine and effect of treatment of hypertension on renal function. Results from the hypertension detection and follow-up program. The Hypertension Detection and Follow-up Program Cooperative Group. Hypertension 1989; 13:I80–93.CrossRefPubMedGoogle Scholar
  11. 11.
    Davis C, Tait G, Carroll J, Wijeysundera DN, Beattie WS. The Revised Cardiac Risk Index in the new millennium: a single-centre prospective cohort re-evaluation of the original variables in 9,519 consecutive elective surgical patients. Can J Anaesth 2013; 60:855–863.CrossRefPubMedGoogle Scholar
  12. 12.
    Lee TH, Marcantonio ER, Mangione CM, Thomas EJ, Polanczyk CA, Cook EF, Sugarbaker DJ, Donaldson MC, Poss R, Ho KK, Ludwig LE, Pedan A, Goldman L. Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery. Circulation 1999; 100:1043–1049.CrossRefPubMedGoogle Scholar
  13. 13.
    Nakazato T, Nakamura T, Sekiya N, Sawa Y. Preoperative estimated glomerular filtration rate is an independent predictor of late cardiovascular morbidity after mitral valve surgery. Ann Thorac Cardiovasc Surg 2014; 20:390–397.CrossRefPubMedGoogle Scholar
  14. 14.
    Walsh SR, Tang T, Sadat U, Varty K, Boyle JR, Gaunt ME. Preoperative glomerular filtration rate and outcome following open abdominal aortic aneurysm repair. Vasc Endovascular Surg 2007; 41:225–229.CrossRefPubMedGoogle Scholar
  15. 15.
    Mases A, Sabate S, Guilera N, Sadurni M, Arroyo R, Fau M, Rojo A, Castillo J, Bover J, Sierra P, Canet J, ANESCARDIOCAT Group. Preoperative estimated glomerular filtration rate and the risk of major adverse cardiovascular and cerebrovascular events in non-cardiac surgery. Br J Anaesth 2014; 113:644–651.CrossRefPubMedGoogle Scholar
  16. 16.
    Ackland GL, Moran N, Cone S, Grocott MP, Mythen MG. Chronic kidney disease and postoperative morbidity after elective orthopedic surgery. Anesth Analg 2011; 112:1375–1381.CrossRefPubMedGoogle Scholar
  17. 17.
    Biccard B. Proposed research plan for the derivation of a new Cardiac Risk Index. Anesth Analg 2015; 120:543–553.CrossRefPubMedGoogle Scholar
  18. 18.
    Vatankulu MA, Murat SN, Demircelik B, Turfan M, Sonmez O, Duran M, Bacaksiz A, Ornek E, Tasal A, Goktekin O. Effect of estimated glomerular filtration rate on periprocedural myocardial infarction in patients undergoing elective percutaneous coronary intervention. Ren Fail 2013; 35:931–935.CrossRefPubMedGoogle Scholar
  19. 19.
    Ried M, Puehler T, Haneya A, Schmid C, Diez C. Acute kidney injury in septua- and octogenarians after cardiac surgery. BMC Cardiovasc Disord 2011; 11:52–2261–11-52.CrossRefGoogle Scholar
  20. 20.
    Squires MH, 3rd, Mehta VV, Fisher SB, Lad NL, Kooby DA, Sarmiento JM, Cardona K, Russell MC, Staley CA, 3rd, Maithel SK. Effect of preoperative renal insufficiency on postoperative outcomes after pancreatic resection: a single institution experience of 1,061 consecutive patients. J Am Coll Surg 2014; 218:92–101.CrossRefPubMedGoogle Scholar
  21. 21.
    Levey AS, Coresh J. Chronic kidney disease. Lancet 2012; 379:165–180.CrossRefPubMedGoogle Scholar
  22. 22.
    Levey AS, Inker LA, Coresh J. Chronic kidney disease in older people. JAMA 2015; 314:557–558.CrossRefPubMedGoogle Scholar
  23. 23.
    Glassock R, Delanaye P, El Nahas M. An age-calibrated classification of chronic kidney disease. JAMA 2015; 314:559–560.CrossRefPubMedGoogle Scholar
  24. 24.
    Nitta K, Okada K, Yanai M, Takahashi S. Aging and chronic kidney disease. Kidney Blood Press Res 2013; 38:109–120.CrossRefPubMedGoogle Scholar
  25. 25.
    Glassock RJ, Winearls C. Ageing and the glomerular filtration rate: truths and consequences. Trans Am Clin Climatol Assoc 2009; 120:419–428.PubMedPubMedCentralGoogle Scholar
  26. 26.
    O'Hare AM, Bertenthal D, Covinsky KE, Landefeld CS, Sen S, Mehta K, Steinman MA, Borzecki A, Walter LC. Mortality risk stratification in chronic kidney disease: one size for all ages?. J Am Soc Nephrol 2006; 17:846–853.CrossRefPubMedGoogle Scholar
  27. 27.
    Hallan SI, Matsushita K, Sang Y, Mahmoodi BK, Black C, Ishani A, Kleefstra N, Naimark D, Roderick P, Tonelli M, Wetzels JF, Astor BC, Gansevoort RT, Levin A, Wen CP, Coresh J, Chronic kidney disease prognosis consortium. Age and association of kidney measures with mortality and end-stage renal disease. JAMA 2012; 308:2349–2360.CrossRefPubMedPubMedCentralGoogle Scholar
  28. 28.
    American College of Surgeons. User Guide for the Participant Use Data File. Available at: www.facs.org/quality-programs/acs-nsqip/. Accessed February, 2017.
  29. 29.
    Hamilton BH, Ko CY, Richards K, Hall BL. Missing data in the American College of Surgeons National Surgical Quality Improvement Program are not missing at random: implications and potential impact on quality assessments. J Am Coll Surg 2010; 210:125–139.e2.Google Scholar
  30. 30.
    American College of Surgeons. User Guide for the 2014 ACS NSQIP Participant Use Data File. Available at: www.facs.org/quality-programs/acs-nsqip/. Accessed February, 2017.
  31. 31.
    Khuri SF, Daley J, Henderson W, Hur K, Gibbs JO, Barbour G, Demakis J, Irvin G,3rd, Stremple JF, Grover F, McDonald G, Passaro E,Jr, Fabri PJ, Spencer J, Hammermeister K, Aust JB. Risk adjustment of the postoperative mortality rate for the comparative assessment of the quality of surgical care: results of the National Veterans Affairs Surgical Risk Study. J Am Coll Surg 1997; 185:315–327.Google Scholar
  32. 32.
    Khuri SF, Daley J, Henderson W, Hur K, Demakis J, Aust JB, Chong V, Fabri PJ, Gibbs JO, Grover F, Hammermeister K, Irvin G, 3rd, McDonald G, Passaro E, Jr, Phillips L, Scamman F, Spencer J, Stremple JF. The Department of Veterans Affairs’ NSQIP: the first national, validated, outcome-based, risk-adjusted, and peer-controlled program for the measurement and enhancement of the quality of surgical care. National VA Surgical Quality Improvement Program. Ann Surg 1998; 228:491–507.CrossRefPubMedPubMedCentralGoogle Scholar
  33. 33.
    Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF, 3rd, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, Coresh J, CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration). A new equation to estimate glomerular filtration rate. Ann Intern Med 2009; 150:604–612.CrossRefPubMedPubMedCentralGoogle Scholar
  34. 34.
    Chapter 1: Definition and classification of CKD. Kidney Int Suppl (2011) 2013; 3:19–62.Google Scholar
  35. 35.
    Hastie T, Tibshirani R, Friedman J. The elements of statistical learning. New York, New York: Springer, 2009.CrossRefGoogle Scholar
  36. 36.
    Edwards D, Berry JJ. The efficiency of simulation-based multiple comparisons. Biometrics 1987; 43:913–928.CrossRefPubMedGoogle Scholar
  37. 37.
    Gaber AO, Moore LW, Aloia TA, Suki WN, Jones SL, Graviss EA, Knight RJ, Bass BL. Cross-sectional and case-control analyses of the association of kidney function staging with adverse postoperative outcomes in general and vascular surgery. Ann Surg 2013; 258:169–177.CrossRefPubMedGoogle Scholar
  38. 38.
    Accetta NA, Gladstone EH, DiSogra C, Wright EC, Briggs M, Narva AS. Prevalence of estimated GFR reporting among US clinical laboratories. Am J Kidney Dis 2008; 52:778–787.CrossRefPubMedPubMedCentralGoogle Scholar
  39. 39.
    Levey AS, Inker LA, Coresh J. GFR estimation: from physiology to public health. Am J Kidney Dis 2014; 63:820–834.CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© The Society for Surgery of the Alimentary Tract 2018

Authors and Affiliations

  • Derrick Antoniak
    • 1
    • 2
  • Chandrakanth Are
    • 3
  • Chad Vokoun
    • 1
  • Kaeli Samson
    • 4
  • Lynette Smith
    • 4
  • Jason Shiffermiller
    • 1
  1. 1.Department of Medicine, Division of General Internal Medicine – AcademicUniversity of Nebraska Medical CenterOmahaUSA
  2. 2.Department of MedicineVeterans Affairs Nebraska Western Iowa Health Care SystemOmahaUSA
  3. 3.Department of Surgery, Division of Surgical Oncology, Fred and Pamela Buffett Cancer CenterUniversity of Nebraska Medical CenterOmahaUSA
  4. 4.Department of Biostatistics, College of Public HealthUniversity of Nebraska Medical CenterOmahaUSA

Personalised recommendations